Stock Screener App

무료 -

설치하다

34.86

1.81% 0.62

Newamsterdam Pharma Company Nv (NAMS)

개요 뉴스 가격 이력 Financials NAMS 왜 하락? 토론 예측

Newamsterdam Pharma Company Nv 주식(NAMS)의 최신 뉴스

Momentum Shift: Should I trade or invest in NewAmsterdam Pharma Company NV2025 Support & Resistance & Reliable Momentum Entry Alerts - baoquankhu1.vn

Breakouts Watch: Will NewAmsterdam Pharma Company NV benefit from sector rotationBond Market & Fast Gain Stock Tips - baoquankhu1.vn

NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Keybank National Association OH Acquires New Stake in NewAmsterdam Pharma Company N.V. $NAMS - Defense World

NewAmsterdam Pharma to Present at the Guggenheim Emerging Outlook: Biotech Summit - The Manila Times

Understanding Momentum Shifts in (NAMS) - Stock Traders Daily

NewAmsterdam Pharma (NAMS) Stock Analysis: Healthcare Innovator with 54% Potential Upside - DirectorsTalk Interviews

Published on: 2026-02-02 19:49:09 - baoquankhu1.vn

Aug Highlights: Should I trade or invest in NewAmsterdam Pharma Company NV2025 Breakouts & Breakdowns & Stepwise Swing Trade Plans - baoquankhu1.vn

Atle Fund Management AB Purchases 36,402 Shares of NewAmsterdam Pharma Company N.V. $NAMS - MarketBeat

Louise Frederika Kooij Sells 39,816 Shares of NewAmsterdam Pharma (NASDAQ:NAMS) Stock - Defense World

Buyback Watch: What are the risks of holding NewAmsterdam Pharma Company NV Equity WarrantJuly 2025 WrapUp & Weekly High Momentum Picks - baoquankhu1.vn

Take Profit: Can NewAmsterdam Pharma Company NV benefit from deglobalizationJuly 2025 Selloffs & Advanced Swing Trade Entry Alerts - baoquankhu1.vn

NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat

NewAmsterdam Pharma (NASDAQ:NAMS) CAO Louise Frederika Kooij Sells 39,816 Shares of Stock - MarketBeat

NewAmsterdam Pharma (NASDAQ:NAMS) CAO Sells $1,037,061.60 in Stock - MarketBeat

Will NewAmsterdam Pharma Company N.V. stock recover after earningsWeekly Trade Report & Capital Protection Trading Alerts - mfd.ru

(NAMSW) and the Role of Price-Sensitive Allocations - Stock Traders Daily

Is NewAmsterdam Pharma Company N.V.’s ROIC above industry averageEarnings Growth Summary & Step-by-Step Swing Trade Plans - mfd.ru

NewAmsterdam Pharma (NASDAQ:NAMS) CAO Louise Frederika Kooij Sells 38,172 Shares of Stock - MarketBeat

NewAmsterdam Pharma (NAMS) Stock Analysis: A Biotech Gem With 52% Upside Potential - DirectorsTalk Interviews

Bond Watch: Is ACOG a good ESG investment2025 Market Sentiment & Community Consensus Stock Picks - baoquankhu1.vn

Quarterly Recap: Is ESLT benefiting from innovation trendsTake Profit & Weekly Top Stock Performers List - baoquankhu1.vn

NewAmsterdam Pharma Company N.V. $NAMS Shares Acquired by Jennison Associates LLC - MarketBeat

Avoiding Lag: Real-Time Signals in (NAMS) Movement - Stock Traders Daily

Stock Recap: Will NewAmsterdam Pharma Company NV Equity Warrant benefit from AI trendsMarket Risk Analysis & Fast Moving Stock Trade Plans - baoquankhu1.vn

Update Report: Will NewAmsterdam Pharma Company NV Equity Warrant benefit from AI trends2025 Market WrapUp & Free Weekly Watchlist of Top Performers - baoquankhu1.vn

Assessing NewAmsterdam Pharma Co: Insights From 5 Financial Analysts - Benzinga

NewAmsterdam Pharma (NAMS) Stock Analysis: Evaluating The 52.72% Potential Upside - DirectorsTalk Interviews

Risks Report: Does HONDW stock have upside surprise potentialEarnings Overview Summary & Accurate Buy Signal Alerts - baoquankhu1.vn

Responsive Playbooks and the NAMSW Inflection - Stock Traders Daily

Aug Intraday: Will NewAmsterdam Pharma Company NV benefit from seasonalityJuly 2025 Price Swings & Daily Momentum Trading Reports - baoquankhu1.vn

Fed Meeting: Is NewAmsterdam Pharma Company NV Equity Warrant exposed to political riskPortfolio Return Summary & Daily Oversold Bounce Ideas - baoquankhu1.vn

Gains Report: What is the implied volatility of Drugs Made In America Acquisition Corp Equity RightWeekly Trade Analysis & AI Enhanced Execution Alerts - baoquankhu1.vn

Exit Recap: Is NewAmsterdam Pharma Company NV Equity Warrant exposed to political riskBear Alert & AI Enhanced Trading Alerts - baoquankhu1.vn

First Week of March 20th Options Trading For NewAmsterdam Pharma (NAMS) - Nasdaq

Relative Strength Alert For NewAmsterdam Pharma Company - Nasdaq

Aug Action: Does NewAmsterdam Pharma Company NV Equity Warrant align with a passive investing strategy2025 Historical Comparison & Precise Entry and Exit Recommendations - baoquankhu1.vn

Assessing NewAmsterdam Pharma (NAMS) Valuation After Recent Share Price Volatility - Yahoo Finance

Aug Rallies: How NewAmsterdam Pharma Company NV stock compares to market leadersPortfolio Update Summary & High Return Trade Guides - Bộ Nội Vụ

NewAmsterdam Pharma (NAMS) Stock Analysis: A Biotech With 46% Upside Potential - DirectorsTalk Interviews

Discipline and Rules-Based Execution in NAMS Response - Stock Traders Daily

NewAmsterdam Pharma (NASDAQ:NAMS) Trading Down 6.5%Time to Sell? - MarketBeat

NewAmsterdam expects EMA decision on cholesterol drug in second half 2026 - Investing.com Australia

NewAmsterdam Pharma outlines 2026 goals after strong 2025 progress - TipRanks

NewAmsterdam expects EMA decision on cholesterol drug in second half 2026 By Investing.com - Investing.com South Africa

NewAmsterdam Pharma Updates on Obicetrapib Clinical Development and EMA Approval Timeline - Quiver Quantitative

Drug in late-stage tests cuts cholesterol and an Alzheimer’s marker - Stock Titan

Can NewAmsterdam Pharma Company N.V. stock continue upward trendModel Comparison & how to pick the right width - Улправда

Why NewAmsterdam Pharma Company N.V. Equity Warrant stock attracts high net worth investorsJuly 2025 Selloffs & Reliable Volume Spike Alerts - ulpravda.ru

Can NewAmsterdam Pharma Company N.V. (KH6) stock hold up in economic slowdownMarket Activity Summary & AI Forecasted Entry and Exit Points - Улправда

Is NewAmsterdam Pharma Company N.V. Equity Warrant stock near bottom after declineAnalyst Upgrade & Verified Chart Pattern Signals - ulpravda.ru

Will NewAmsterdam Pharma Company N.V. Equity Warrant stock gain from strong economy2025 Historical Comparison & Community Consensus Stock Picks - Улправда

What dividend safety score for NewAmsterdam Pharma Company N.V. stock2025 Technical Patterns & Low Risk High Reward Ideas - Улправда

RPRX

$44.80

1.24%

ROIV

$26.75

0.19%

INCY

$100.75

1.93%

BNTX

$105.76

3.31%

INSM

$146.17

1.52%

ONC

$346.42

1.38%

야후에서 열기 | 구글에서 열기 | 핀비즈에서 열기 | MarketWatch에서 열기 | EDGAR에서 열기 | 로이터에서 공개